GVS
870976
Nexwise Intelligence China
301248
Astro-century Education & Technology
300654
4
Hand Enterprise Solutions
300170
5
Synthesis Electronic Technology
300479
CN Stock MarketDetailed Quotes
300636 Jiangxi Synergy Pharmaceutical
- 7.86
- -0.05-0.63%
Trading Jan 24 11:12 CST
3.31BMarket Cap26.92P/E (TTM)
7.92High7.81Low16.00KlotVolume7.90Open7.91Pre Close12.57MTurnover0.44%Turnover Ratio31.31P/E (Static)421.53MShares11.4652wk High1.43P/B2.86BFloat Cap5.7252wk Low9.49Limit Up364.42MShs Float26.04Historical High6.33Limit Down1.39%Amplitude3.86Historical Low0.04Dividend TTM7.86Avg Price11.03KlotAsk0.51%Div YieldTTM100Lot Size4.79KlotBid
Jiangxi Synergy Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.84%569.93M | 0.08%382.05M | -6.47%206.45M | 0.31%722.14M | 5.94%559.66M | 13.63%381.75M | 22.79%220.75M | 21.58%719.91M | 23.43%528.27M | 21.06%335.98M |
| Operating revenue | 1.84%569.93M | 0.08%382.05M | -6.47%206.45M | 0.31%722.14M | 5.94%559.66M | 13.63%381.75M | 22.79%220.75M | 21.58%719.91M | 23.43%528.27M | 21.06%335.98M |
| Other operating revenue | ---- | -88.54%398.4K | ---- | 8.95%1.43M | ---- | 668.20%3.48M | ---- | -56.93%1.32M | ---- | -83.57%452.38K |
| Total operating cost | -4.44%455.18M | -9.61%295.17M | -15.81%150.66M | -1.47%599.9M | 5.31%476.32M | 10.93%326.54M | 19.92%178.96M | 21.95%608.85M | 27.42%452.32M | 28.55%294.37M |
| Operating cost | -1.68%378.09M | -1.71%250.14M | -7.61%130.75M | -0.99%481.66M | 2.98%384.57M | 5.42%254.5M | 13.57%141.52M | 17.71%486.45M | 24.93%373.42M | 23.26%241.43M |
| Operating tax surcharges | 91.99%5.38M | 94.30%3.39M | -1.19%859.07K | 53.22%3.66M | 58.28%2.8M | 50.19%1.75M | 46.32%869.46K | 31.48%2.39M | 28.99%1.77M | 28.90%1.16M |
| Operating expense | 6.34%18.67M | 6.96%12.66M | 11.80%5.93M | 42.15%26.26M | 41.43%17.56M | 30.28%11.84M | 4.76%5.3M | 2.45%18.47M | -6.62%12.42M | 18.56%9.09M |
| Administration expense | -3.93%26.86M | -8.43%17.44M | -7.32%8.4M | 4.95%34.57M | 32.33%27.96M | 48.03%19.05M | 37.58%9.06M | 38.59%32.94M | 39.76%21.13M | 37.54%12.87M |
| Financial expense | -222.19%-13.03M | -1,316.80%-10.65M | -285.55%-5.57M | -222.29%-9.4M | -277.69%-4.04M | -78.79%875.1K | 235.71%3M | 128.49%7.69M | 15.74%2.28M | 643.10%4.13M |
| -Interest expense (Financial expense) | 113.71%13.18M | 102.02%8.91M | 182.30%4.06M | 28.53%9.9M | 103.36%6.17M | 24.43%4.41M | -17.67%1.44M | 35.31%7.7M | -22.55%3.03M | 34.25%3.55M |
| -Interest Income (Financial expense) | -159.61%-23.11M | -491.96%-16.22M | -716.97%-9.01M | -488.68%-17.01M | -333.72%-8.9M | -113.17%-2.74M | -122.64%-1.1M | -48.24%-2.89M | -86.79%-2.05M | -48.65%-1.29M |
| Research and development | -17.42%39.2M | -42.43%22.18M | -46.42%10.29M | 3.68%63.15M | 14.94%47.48M | 49.93%38.53M | 67.09%19.21M | 56.10%60.91M | 69.82%41.31M | 75.53%25.7M |
| Credit Impairment Loss | -26.36%-1.86M | -391.26%-1.99M | -61.14%-2.53M | 107.24%107.34K | -4.29%-1.47M | 14.33%-404.71K | -20.41%-1.57M | 28.18%-1.48M | 12.45%-1.41M | 85.27%-472.4K |
| Asset Impairment Loss | -1,145.43%-12.38M | -377.25%-11.91M | -42.35%-7.92M | -162.12%-19.14M | -132.09%-993.64K | -192.21%-2.5M | ---5.56M | -52.53%-7.3M | --3.1M | --2.71M |
| Other net revenue | -248.78%-8.74M | -263.55%-9.68M | 0.06%-6.76M | -111.91%-10.01M | 60.17%5.88M | 64.22%5.92M | -593.16%-6.77M | -4.62%-4.72M | 508.91%3.67M | 332.55%3.6M |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -200.00%-255.58K | ---481.44K | ---566K |
| Invest income | --606.7K | ---45.88K | ---- | 159.55%567.88K | ---- | ---- | ---- | -4,832.31%-953.63K | -3,696.51%-724.75K | -1,461.92%-274.45K |
| Asset deal income | 20.51%-706.14K | ---706.14K | --0 | -650.05%-1.32M | -404.46%-888.31K | ---- | --0 | 82.48%-176.09K | -23.50%-176.09K | ---- |
| Other revenue | -39.44%5.59M | -43.52%4.98M | 904.91%3.69M | 79.50%9.78M | 174.18%9.23M | 299.35%8.82M | 12.58%366.76K | 77.55%5.45M | 44.02%3.37M | 30.32%2.21M |
| Operating profit | 18.82%106.01M | 26.29%77.21M | 40.02%49.03M | 5.55%112.23M | 12.05%89.22M | 35.22%61.13M | 18.48%35.02M | 20.37%106.33M | 8.16%79.63M | -3.80%45.21M |
| Add:Non operating Income | -99.98%1.36 | ---- | --0 | 1,490.37%354.08K | -69.79%6.73K | -69.79%6.73K | -69.79%6.73K | 3,008,548.65%22.26K | 3,008,548.65%22.26K | 3,008,548.65%22.26K |
| Less:Non operating expense | 677.26%512.91K | 1.15%66.75K | 1.15%66.75K | -58.05%85.99K | 19.98%65.99K | 19.98%65.99K | 19.98%65.99K | --205K | --55K | --55K |
| Total profit | 18.32%105.5M | 26.31%77.14M | 40.07%48.97M | 5.98%112.5M | 12.02%89.16M | 35.18%61.07M | 18.41%34.96M | 20.16%106.15M | 8.12%79.59M | -3.86%45.18M |
| Less:Income tax cost | -7.09%9.76M | 87.69%7.59M | 190.08%5.4M | 18.88%6.52M | 105.76%10.51M | 59.18%4.04M | -30.91%1.86M | -24.08%5.48M | -27.78%5.11M | -43.12%2.54M |
| Net profit | 21.72%95.74M | 21.96%69.55M | 31.62%43.56M | 5.28%105.98M | 5.59%78.65M | 33.75%57.03M | 23.36%33.1M | 24.10%100.67M | 11.93%74.49M | 0.26%42.64M |
| Net profit from continuing operation | 21.72%95.74M | 21.96%69.55M | ---- | 5.28%105.98M | 5.59%78.65M | 33.75%57.03M | ---- | 24.10%100.67M | 11.93%74.49M | 0.26%42.64M |
| Net profit of parent company owners | 21.72%95.74M | 21.96%69.55M | 31.62%43.56M | 5.28%105.98M | 5.59%78.65M | 33.75%57.03M | 23.36%33.1M | 24.10%100.67M | 11.93%74.49M | 0.26%42.64M |
| Earning per share | ||||||||||
| Basic earning per share | 6.39%0.228 | 2.16%0.1656 | 9.74%0.1037 | -9.66%0.2786 | -7.47%0.2143 | 18.93%0.1621 | 8.75%0.0945 | 17.40%0.3084 | 5.27%0.2316 | -34.03%0.1363 |
| Diluted earning per share | 6.34%0.228 | 2.35%0.1656 | 10.44%0.1037 | -4.20%0.2786 | -7.43%0.2144 | 28.31%0.1618 | 18.41%0.0939 | 21.02%0.2908 | 15.80%0.2316 | -33.21%0.1261 |
| Other composite income | ||||||||||
| Total composite income | 21.72%95.74M | 21.96%69.55M | 31.62%43.56M | 5.28%105.98M | 5.59%78.65M | 33.75%57.03M | 23.36%33.1M | 24.10%100.67M | 11.93%74.49M | 0.26%42.64M |
| Total composite income of parent company owners | 21.72%95.74M | 21.96%69.55M | 31.62%43.56M | 5.28%105.98M | 5.59%78.65M | 33.75%57.03M | 23.36%33.1M | 24.10%100.67M | 11.93%74.49M | 0.26%42.64M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.